AIM : Up-regulation of soluble CD40 ligand (sCD40L) and of monocyte chemoattractant protein-1 (MCP-1) has been found in diabetes and in patients with acute cerebral ischemia.
AIMS/HYPOTHESIS : Monocyte chemoattractant protein-1 (MCP-1) attracts monocytes and T lymphocytes , and could thus contribute to mononuclear cell infiltration in Type I (insulin-dependent) diabetes mellitus.
Nitric oxide (NO) has been implicated as an immunological effector molecule that mediates beta-cell dysfunction associated with Type 1 diabetes.
Nitric oxide (NO) stimulated ADP-ribosylation of PARS in rat brain.